Quoin Cash And Short Term Investments vs Non Currrent Assets Other Analysis

QNRX Stock  USD 0.62  0.01  1.59%   
Quoin Pharmaceuticals financial indicator trend analysis is much more than just breaking down Quoin Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Quoin Pharmaceuticals is a good investment. Please check the relationship between Quoin Pharmaceuticals Cash And Short Term Investments and its Non Currrent Assets Other accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quoin Pharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

Cash And Short Term Investments vs Non Currrent Assets Other

Cash And Short Term Investments vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Quoin Pharmaceuticals Cash And Short Term Investments account and Non Currrent Assets Other. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Quoin Pharmaceuticals' Cash And Short Term Investments and Non Currrent Assets Other is 0.44. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Quoin Pharmaceuticals Ltd, assuming nothing else is changed. The correlation between historical values of Quoin Pharmaceuticals' Cash And Short Term Investments and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Quoin Pharmaceuticals Ltd are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Cash And Short Term Investments i.e., Quoin Pharmaceuticals' Cash And Short Term Investments and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.44
Relationship DirectionPositive 
Relationship StrengthWeak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Quoin Pharmaceuticals balance sheet. This account contains Quoin Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Quoin Pharmaceuticals Ltd fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Quoin Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Quoin Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quoin Pharmaceuticals Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Selling General Administrative is likely to drop to about 4 M in 2024. Sales General And Administrative To Revenue is likely to drop to -26.89 in 2024
 2023 2024 (projected)
Reconciled Depreciation119.6K96.1K
Cost Of Revenue103.4K102.9K

Quoin Pharmaceuticals fundamental ratios Correlations

0.920.23-0.10.720.680.810.590.220.340.56-0.090.08-0.280.050.31-0.23-0.020.330.01-0.090.01-0.06-0.22-0.090.06
0.92-0.12-0.270.510.40.90.330.470.180.3-0.260.25-0.58-0.10.57-0.27-0.240.460.08-0.260.08-0.3-0.52-0.260.27
0.23-0.120.350.320.76-0.220.68-0.780.690.70.35-0.350.730.6-0.51-0.120.68-0.17-0.30.35-0.30.760.840.35-0.75
-0.1-0.270.350.30.09-0.240.14-0.330.170.181.0-1.00.630.13-0.690.080.70.050.11.00.10.610.51.0-0.2
0.720.510.320.30.690.390.69-0.050.320.680.31-0.310.030.03-0.04-0.110.20.230.010.310.010.130.00.310.01
0.680.40.760.090.690.250.78-0.520.620.780.1-0.10.360.39-0.17-0.150.35-0.02-0.270.1-0.270.380.440.1-0.42
0.810.9-0.22-0.240.390.250.010.63-0.17-0.02-0.230.23-0.53-0.440.340.12-0.470.10.31-0.230.31-0.52-0.59-0.230.53
0.590.330.680.140.690.780.01-0.450.821.00.15-0.150.190.660.1-0.540.590.44-0.320.15-0.320.590.390.15-0.6
0.220.47-0.78-0.33-0.05-0.520.63-0.45-0.66-0.49-0.330.32-0.76-0.650.480.19-0.670.140.45-0.330.45-0.75-0.85-0.330.77
0.340.180.690.170.320.62-0.170.82-0.660.840.17-0.170.230.820.12-0.680.710.51-0.430.18-0.430.740.480.17-0.77
0.560.30.70.180.680.78-0.021.0-0.490.840.19-0.190.230.690.07-0.540.630.43-0.330.19-0.330.630.430.19-0.63
-0.09-0.260.351.00.310.1-0.230.15-0.330.170.19-1.00.630.13-0.680.080.70.060.11.00.10.60.51.0-0.2
0.080.25-0.35-1.0-0.31-0.10.23-0.150.32-0.17-0.19-1.0-0.62-0.130.68-0.07-0.7-0.06-0.1-1.0-0.1-0.6-0.49-1.00.2
-0.28-0.580.730.630.030.36-0.530.19-0.760.230.230.63-0.620.4-0.860.140.67-0.42-0.310.63-0.310.720.940.63-0.6
0.05-0.10.60.130.030.39-0.440.66-0.650.820.690.13-0.130.40.08-0.790.780.47-0.740.13-0.740.840.660.13-0.96
0.310.57-0.51-0.69-0.04-0.170.340.10.480.120.07-0.680.68-0.860.08-0.58-0.370.67-0.14-0.68-0.14-0.39-0.68-0.680.16
-0.23-0.27-0.120.08-0.11-0.150.12-0.540.19-0.68-0.540.08-0.070.14-0.79-0.58-0.48-0.850.70.070.7-0.48-0.10.080.62
-0.02-0.240.680.70.20.35-0.470.59-0.670.710.630.7-0.70.670.78-0.37-0.480.35-0.380.7-0.380.980.790.7-0.8
0.330.46-0.170.050.23-0.020.10.440.140.510.430.06-0.06-0.420.470.67-0.850.35-0.260.06-0.260.26-0.230.06-0.22
0.010.08-0.30.10.01-0.270.31-0.320.45-0.43-0.330.1-0.1-0.31-0.74-0.140.7-0.38-0.260.11.0-0.48-0.430.10.73
-0.09-0.260.351.00.310.1-0.230.15-0.330.180.191.0-1.00.630.13-0.680.070.70.060.10.10.60.51.0-0.2
0.010.08-0.30.10.01-0.270.31-0.320.45-0.43-0.330.1-0.1-0.31-0.74-0.140.7-0.38-0.261.00.1-0.48-0.430.10.73
-0.06-0.30.760.610.130.38-0.520.59-0.750.740.630.6-0.60.720.84-0.39-0.480.980.26-0.480.6-0.480.860.6-0.89
-0.22-0.520.840.50.00.44-0.590.39-0.850.480.430.5-0.490.940.66-0.68-0.10.79-0.23-0.430.5-0.430.860.5-0.82
-0.09-0.260.351.00.310.1-0.230.15-0.330.170.191.0-1.00.630.13-0.680.080.70.060.11.00.10.60.5-0.2
0.060.27-0.75-0.20.01-0.420.53-0.60.77-0.77-0.63-0.20.2-0.6-0.960.160.62-0.8-0.220.73-0.20.73-0.89-0.82-0.2
Click cells to compare fundamentals

Quoin Pharmaceuticals Account Relationship Matchups

Quoin Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.2M1.4M9.4M14.5M12.2M11.7M
Total Stockholder Equity4.3M(6.6M)657.0K7.4M5.7M6.6M
Property Plant And Equipment Net1.4M1.3M672.6K1.9M2.2M1.3M
Net Debt(4.9M)889.5K736.4M(2.9M)(2.4M)(2.3M)
Cash5.2M323.8K7.5M2.9M2.4M4.0M
Non Current Assets Total794.7K912.6K858.6K1.1M883.3K1.0M
Other Assets15.3M1.050K383.4K345.1K327.8K
Cash And Short Term Investments5.2M323.8K7.5M12.9M10.7M8.0M
Common Stock Shares Outstanding3.5K20.0K26.4K403.9K900.9K855.9K
Liabilities And Stockholders Equity6.2M1.4M9.4M14.5M12.2M11.7M
Other Stockholder Equity28.7M100.028.7M44.9M51.9M28.7M
Total Current Assets5.4M465.2K8.5M13.4M11.3M8.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Quoin Stock Analysis

When running Quoin Pharmaceuticals' price analysis, check to measure Quoin Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quoin Pharmaceuticals is operating at the current time. Most of Quoin Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Quoin Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quoin Pharmaceuticals' price. Additionally, you may evaluate how the addition of Quoin Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.